Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 42291-565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 42291-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inner (565 28 Inner Carton)

Inner (565 28 Inner Carton)
This appears to be a label from a medication container. The medication is named "AVKARE" and the National Drug Code (NDC) is £229156525. The label indicates that the medication should be stored at room temperature and protected from light. There is also a code "Q2S4S 5" present, but it is unclear what it refers to.*
FDA Label Image

Outer (565 84 Outer Carton)

FDA Label Image

Blister (Blister Pack)

FDA Label Image

Chart 1

Chart 1
Available*
FDA Label Image

Ethinyl (Ethinyl Estradiol)

Ethinyl (Ethinyl Estradiol)
Etinyl Estradiol is a medication used in combination with other drugs to prevent pregnancy. It is a type of estrogen and works by preventing ovulation and changing the cervical mucus to make it harder for sperm to reach the uterus. This medication is available in pill form and is taken orally once a day at the same time each day. It is important to follow the instructions given by your healthcare provider for the safest and most effective use of Etinyl Estradiol.*
FDA Label Image

Figure 2

Figure 2
The text describes a Figure 2 that shows the risk of breast cancer associated with different studies on combined oral contraceptive (COC) use. The studies include NICHO Women's Contraceptive Study, French E3N cohort study, Shangal Women's Health Study, The Nurses' Health Study, Oxford Family Planning Association study, and NICHD Women's Contraceptive study. The studies are divided into two categories: Ever Use and Current Use of COCs. The Effect Estimate is presented in the form of OR/RR, where RR stands for relative risk, OR for odds ratio, and HR for hazard ratio. The study includes the definitions of "ever COC use" and "never COC use".*
FDA Label Image

Norgestimate (Norgestimate)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.